Skip to main content
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2022 Nov 22;10:1075376. doi: 10.3389/fchem.2022.1075376

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Xin-Ya Shi 1, Ting-Xiao Shen 2, Ao-Lin Zhang 2, Li-Tao Tan 2, Wen-Chang Shen 2, Hai-Jiang Zhong 2, Shun-Lin Zhang 3,*, Yu-Lan Gu 1,*, Lei Shen 2,*
PMCID: PMC9724231  PMID: 36482938

In the original article, there was an error in Figure 6D, page 6, as published. The corrected figure appears below.

FIGURE 6.

FIGURE 6

(A–C) In vitro MTT assay of HeLa, HepG2, and HT29 cells was treated with ligand H4L and complex NPs; trypan blue fluorescent staining of the control group for (D) HeLa cells, (E) HepG2 cells, and (F) HT29 cells; Complex NPs for (G) HeLa cells (H) HepG2 cells (I) HT29 cells.

In the original article, there was an error in the caption for Figure 6, page 6, as published. The corrected caption appears below.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES